Literature DB >> 33726794

Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA.

Chang Liu1, Qinghai Dai2, Qian Ding3, Min Wei4,5, Xiaohong Kong6.   

Abstract

Chronic Infection of Hepatitis B virus (HBV) is one risk factor of hepatocellular carcinoma (HCC). Much effort has been made to research the process of HBV-associated HCC, but its molecular mechanisms of carcinogenesis remain vague. Here, weighted gene co-expression network analysis (WGCNA) was employed to explore the co-expressed modules and hub/key genes correlated to HBV-associated HCC. We found that genes of the most significant module related to HBV-associated HCC were enriched in DNA replication, p53 signaling pathway, cell cycle, and HTLV-1 infection associated pathway; these cellular pathways played critical roles in the initiation and development of HCC or viral infections. Furthermore, seven hub/key genes were identified based on the topological network analysis, and their roles in HCC were verified by expression and Kaplan-Meier survival analysis. Protein-protein interaction and KEGG pathway analysis suggested that these key genes may stimulate cellular proliferation to promote the HCC progression. This study provides new perspectives to the knowledge of the key pathways and genes in the carcinogenesis process of HBV-associated HCC, and our findings provided potential therapeutic targets and clues of the carcinogenesis of HBV-associated HCC.

Entities:  

Keywords:  Cell cycle; HBV; HCC; K-M survival; Mitosis; WGCNA

Year:  2021        PMID: 33726794      PMCID: PMC7962393          DOI: 10.1186/s13027-021-00357-4

Source DB:  PubMed          Journal:  Infect Agent Cancer        ISSN: 1750-9378            Impact factor:   2.965


  46 in total

1.  WGCNA Application to Proteomic and Metabolomic Data Analysis.

Authors:  G Pei; L Chen; W Zhang
Journal:  Methods Enzymol       Date:  2016-12-15       Impact factor: 1.600

Review 2.  The evolving epidemiology of hepatocellular carcinoma: a global perspective.

Authors:  Michael C Wallace; David Preen; Gary P Jeffrey; Leon A Adams
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-04-01       Impact factor: 3.869

Review 3.  The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease.

Authors:  Mark A Feitelson; Barbara Bonamassa; Alla Arzumanyan
Journal:  Expert Opin Ther Targets       Date:  2014-01-03       Impact factor: 6.902

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

5.  Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

Authors:  Giovanni Sitia; Roberto Aiolfi; Pietro Di Lucia; Marta Mainetti; Amleto Fiocchi; Francesca Mingozzi; Antonio Esposito; Zaverio M Ruggeri; Francis V Chisari; Matteo Iannacone; Luca G Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 6.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

7.  NCBI GEO: archive for functional genomics data sets--update.

Authors:  Tanya Barrett; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Michelle Holko; Andrey Yefanov; Hyeseung Lee; Naigong Zhang; Cynthia L Robertson; Nadezhda Serova; Sean Davis; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

8.  ArrayExpress--a public database of microarray experiments and gene expression profiles.

Authors:  H Parkinson; M Kapushesky; M Shojatalab; N Abeygunawardena; R Coulson; A Farne; E Holloway; N Kolesnykov; P Lilja; M Lukk; R Mani; T Rayner; A Sharma; E William; U Sarkans; A Brazma
Journal:  Nucleic Acids Res       Date:  2006-11-28       Impact factor: 16.971

9.  ArrayExpress update--simplifying data submissions.

Authors:  Nikolay Kolesnikov; Emma Hastings; Maria Keays; Olga Melnichuk; Y Amy Tang; Eleanor Williams; Miroslaw Dylag; Natalja Kurbatova; Marco Brandizi; Tony Burdett; Karyn Megy; Ekaterina Pilicheva; Gabriella Rustici; Andrew Tikhonov; Helen Parkinson; Robert Petryszak; Ugis Sarkans; Alvis Brazma
Journal:  Nucleic Acids Res       Date:  2014-10-31       Impact factor: 16.971

Review 10.  Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.

Authors:  Arnolfo Petruzziello
Journal:  Open Virol J       Date:  2018-02-28
View more
  3 in total

1.  Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.

Authors:  Aliakbar Hasankhani; Abolfazl Bahrami; Negin Sheybani; Behzad Aria; Behzad Hemati; Farhang Fatehi; Hamid Ghaem Maghami Farahani; Ghazaleh Javanmard; Mahsa Rezaee; John P Kastelic; Herman W Barkema
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

2.  Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance.

Authors:  Hua Ye; Mengxia Sun; Shiliang Huang; Feng Xu; Jian Wang; Huiwei Liu; Liangshun Zhang; Wenjing Luo; Wenying Guo; Zhe Wu; Jie Zhu; Hong Li
Journal:  Int J Gen Med       Date:  2021-12-04

3.  Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).

Authors:  Mohadeseh Zarei Ghobadi; Rahman Emamzadeh
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.